• xxx


Consultant Clinical Oncologist MA MBBS MRCP FRCR MD, Thoracic malignancies Royal Marsden
“Developments in radiotherapy, within lung cancer”

Dr McDonald’s research aims to improve outcomes by developing individualised approaches to lung radiotherapy through integration of novel functional imaging, targeted biological agents and immunotherapy with advanced radiotherapy technologies, including stereotactic radiotherapy, intensity-modulated and image-guided adaptive radiotherapy. She is the deputy clinical lead in the International Atlantic Consortium for novel developmental work on Magnetic Resonance (MR) guided radiotherapy for lung cancer and the chief investigator for the HALT trial investigating SBRT in oligo-progressive disease in patients with mutation positive NSCLC.